Value proposition

Pioneering AI-based cancer diagnostics in pathology

Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology.

Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity.

We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist.

Our GalenTM platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity.

Deployed worldwide, Galen is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis.

We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: transform cancer diagnosis with AI and improve patient care.

If you are an outstanding professional constantly looking for challenges, passionate about your work, a team player and want to make real impact – we want to hear from you.

machine learning, algorithms , cancer diagnostics, deep learning, computer vision, digital pathology, digital health, artificial intelligence, healthcare, computational pathology, oncology, urology, precision medicine, predictive analytics, and pathology